Vetr Inc. Upgrades Biogen Inc (BIIB) to Strong-Buy

Vetr Inc. Upgrades Biogen Inc (BIIB) to Strong-Buy


The firm presently has a $312.67 price objective on the biotechnology company's stock. Vetr 's price target would suggest a potential upside of 13.01% from the company's current price.



from Biotech News